RT @EQRxINC: We just announced positive results for the Phase 3 study of our anti-PD-L1 therapy in Stage III #NSCLC.
We are committed to…
RT @EQRxINC: We just announced positive results for the Phase 3 study of our anti-PD-L1 therapy in Stage III #NSCLC.
We are committed to…
© Nextech Invest Ltd. | privacy policy